222 related articles for article (PubMed ID: 28505480)
1. Triphenyltin(IV) benzoates with diazenyl/imino scaffold exhibiting remarkable apoptosis mediated by reactive oxygen species.
Basu Baul TS; Dutta D; Duthie A; Prasad R; Rana NK; Koch B; Tiekink ERT
J Inorg Biochem; 2017 Aug; 173():79-92. PubMed ID: 28505480
[TBL] [Abstract][Full Text] [Related]
2. An in vitro comparative assessment with a series of new triphenyltin(IV) 2-/4-[(E)-2-(aryl)-1-diazenyl]benzoates endowed with anticancer activities: structural modifications, analysis of efficacy and cytotoxicity involving human tumor cell lines.
Basu Baul TS; Paul A; Pellerito L; Scopelliti M; Duthie A; de Vos D; Verma RP; Englert U
J Inorg Biochem; 2012 Feb; 107(1):119-28. PubMed ID: 22182574
[TBL] [Abstract][Full Text] [Related]
3. Advancement towards tin-based anticancer chemotherapeutics: structural modification and computer modeling approach to drug-enzyme interactions.
Basu Baul TS; Dutta D; de Vos D; Höpfl H; Pooja ; Singh P
Curr Top Med Chem; 2012; 12(24):2810-26. PubMed ID: 23368104
[TBL] [Abstract][Full Text] [Related]
4. Triphenylstannyl((arylimino)methyl)benzoates with selective potency that induce G1 and G2/M cell cycle arrest and trigger apoptosis via ROS in human cervical cancer cells.
Basu Baul TS; Longkumer I; Duthie A; Singh P; Koch B; Guedes da Silva MFC
Dalton Trans; 2018 Feb; 47(6):1993-2008. PubMed ID: 29345708
[TBL] [Abstract][Full Text] [Related]
5. Molecular basis of the interaction of novel tributyltin(IV) 2/4-[(E)-2-(aryl)-1-diazenyl]benzoates endowed with an improved cytotoxic profile: synthesis, structure, biological efficacy and QSAR studies.
Basu Baul TS; Paul A; Pellerito L; Scopelliti M; Pellerito C; Singh P; Verma P; Duthie A; de Vos D; Verma RP; Englert U
J Inorg Biochem; 2010 Sep; 104(9):950-66. PubMed ID: 20553814
[TBL] [Abstract][Full Text] [Related]
6. The triphenyltin(VI) complexes of NSAIDs and derivatives. Synthesis, crystal structure and antiproliferative activity. Potent anticancer agents.
Dokorou V; Primikiri A; Kovala-Demertzi D
J Inorg Biochem; 2011 Feb; 105(2):195-201. PubMed ID: 21194618
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, photophysical properties and structures of organotin-Schiff bases utilizing aromatic amino acid from the chiral pool and evaluation of the biological perspective of a triphenyltin compound.
Basu Baul TS; Kehie P; Duthie A; Guchhait N; Raviprakash N; Mokhamatam RB; Manna SK; Armata N; Scopelliti M; Wang R; Englert U
J Inorg Biochem; 2017 Mar; 168():76-89. PubMed ID: 28024187
[TBL] [Abstract][Full Text] [Related]
8. Triphenyltin(IV) 2-[(E)-2-(aryl)-1-diazenyl]benzoates as anticancer drugs: synthesis, structural characterization, in vitro cytotoxicity and study of its influence towards the mechanistic role of some key enzymes.
Basu Baul TS; Paul A; Pellerito L; Scopelliti M; Singh P; Verma P; de Vos D
Invest New Drugs; 2010 Oct; 28(5):587-99. PubMed ID: 19641849
[TBL] [Abstract][Full Text] [Related]
9. Amino acetate functionalized Schiff base organotin(IV) complexes as anticancer drugs: synthesis, structural characterization, and in vitro cytotoxicity studies.
Baul TS; Basu S; de Vos D; Linden A
Invest New Drugs; 2009 Oct; 27(5):419-31. PubMed ID: 18941713
[TBL] [Abstract][Full Text] [Related]
10. Novel mixed ligand di-n-butyltin(IV) complexes derived from acylpyrazolones and fluorinated benzoic acids: synthesis, characterization, cytotoxicity and the induction of apoptosis in Hela cancer cells.
